Eaton Vance Management’s CONMED CNMD Stock Holding History

Eaton Vance Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$270K	Buy	3,369 +19	+0.6%	+$1.79K	﹤0.01%	1452
2022 Q2	$321K	Sell	3,350 -1,149	-26%	-$138K	﹤0.01%	1457
2022 Q1	$668K	Sell	4,499 -36	-0.8%	-$5.03K	﹤0.01%	1454
2021 Q4	$643K	Buy	4,535 +200	+5%	+$28.3K	﹤0.01%	1273
2021 Q3	$423K	Buy	4,335 +32	+0.7%	+$4.19K	﹤0.01%	1241
2021 Q2	$591K	Buy	4,303 +844	+24%	+$116K	﹤0.01%	1309
2021 Q1	$452K	Buy	3,459 +98	+3%	+$11.8K	﹤0.01%	1302
2020 Q4	$376K	Hold	3,361	–	–	﹤0.01%	1277
2020 Q3	$264K	Buy	3,361 +23	+0.7%	+$1.88K	﹤0.01%	1242
2020 Q2	$240K	Buy	+3,338	New	+$232K	﹤0.01%	1232

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Eaton Vance Management's CNMD Position: Q3 2022 in Review

Eaton Vance Management increased its CONMED (CNMD) stake by 0.57% in Q3 2022, buying an estimated $1.79K and bringing the position to 3,369 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #1452.

Eaton Vance Management first reported a position in CNMD in Q2 2020 and has held it in 10 quarters since. The position peaked at $668K in Q1 2022. 250 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

Eaton Vance Management held 3,369 shares of CONMED worth $270K as of Q3 2022.
Eaton Vance Management bought 19 CONMED shares in Q3 2022, an estimated $1.79K.
CONMED made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #1452 holding.
Eaton Vance Management first reported a position in CONMED in Q2 2020 and has held it in 10 quarters since.
Eaton Vance Management's CONMED position peaked at $668K in Q1 2022.
250 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.